Viewing Study NCT03058692


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2026-02-21 @ 4:11 AM
Study NCT ID: NCT03058692
Status: COMPLETED
Last Update Posted: 2020-06-18
First Post: 2017-02-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: 14-0112
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators